Clinical Trial Update: 24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing 24-hour intraocular pressure control with travoprost/timolol fixed combination versus travoprost in glaucoma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Timolol (timolol)
• Travoprost (Travoprost (isomer-free))
• Travoprost/Timolol fixed combination (travoprost; timolol)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Glaucoma | Phase 4 | Status: COMPLETED